Skip to main content

Clinical and Translational Oncology

Ausgabe 2/2023

Inhalt (26 Artikel)

Open Access Review Article

The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility

Yuanshuai Su, Chengzhi Li, Yu Fang, Xinyu Gu, Qiuxian Zheng, Juan Lu, Lanjuan Li

Review Article

A review of literature: role of long noncoding RNA TPT1-AS1 in human diseases

Yi Li, Fulei Li, Zongzong Sun, Juan Li

Review Article

LncRNA NCK1-AS1-mediated regulatory functions in human diseases

Yingfan Wang, Jie Pan, Zongzong Sun

Review Article

The pro-tumorigenic responses in metastatic niches: an immunological perspective

Mohammad Hossein Mirzapour, Mahsa Heidari-Foroozan, Sepideh Razi, Nima Rezaei

Review Article

The stem cell-specific long non-coding RNAs in leukemia

Maryam Farzaneh, Sajad Najafi, Mohadeseh Sheykhi-Sabzehpoush, Fereshteh Nezhad Dehbashi, Omid Anbiyaee, Ava Nasrolahi, Shirin Azizidoost

Review Article

The application of tumor cell-derived vesicles in oncology therapy

Ximei Xu, Yin Xiang, Yang Yang, Kai Liu, Zhiwei Cui, Xiaodong Tong, Junliang Chen, Fang Hou, Zhiqiang Luo

Research Article

Targeted delivery of nuclear targeting probe for bladder cancer using cyclic pentapeptide c(RGDfK) and acridine orange

Jiaxin Qin, Qing Liang, Guangyue Wang, Lin Hao, Xing Liu, Xinlei Wang, Zhengxiang Hu, Gaochuan Fang, Liang Xue, Yan Zhao, Rui Li, Qian Lv, Jiling Wen, Guosheng Yang, Conghui Han, Zhenduo Shi

Research Article

Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking

Yihong Chai, Feng Chen, Zijian Li, Panpan Yang, Qi Zhou, Wenling Liu, Yaming Xi

Research Article

Reirradiation on spine metastases: an Italian survey on behalf of palliative care and reirradiation study groups of Italian association of radiotherapy and clinical oncology (AIRO)

Rossella Di Franco, Donato Pezzulla, Fabio Arcidiacono, Antonio Pontoriero, Francesco Cellini, Liliana Belgioia, Valentina Borzillo, Sara Lillo, Francesco Pastore, Luca Dominici, Silvia Longo, Alberto Cacciola, Antonella Ciabattoni, Alice Zamagni, Giulio Francolini, Antonella Fontana, Esmeralda Scipilliti, Rosario Mazzola, Elisa D’Angelo, Rossana Ingargiola, Paolo Muto, Ernesto Maranzano

Research Article

The value of sentinel lymph-node biopsy in women with node-positive breast cancer at diagnosis and node-negative tumour after neoadjuvant therapy: a systematic review

Juan C. Vázquez, Antonio Piñero, Francisco J. de Castro, Ana Lluch, Miguel Martín, Agustí Barnadas, Emilio Alba, Álvaro Rodríguez-Lescure, Federico Rojo, Julia Giménez, Ivan Solá, Maria J. Quintana, Xavier Bonfill, Gerard Urrutia, Pedro Sánchez-Rovira

Open Access Research Article

Clinical feasibility of combining intraoperative electron radiation therapy with minimally invasive surgery: a potential for electron-FLASH clinical development

Felipe Ángel Calvo Manuel, Javier Serrano, Claudio Solé, Mauricio Cambeiro, Jacobo Palma, Javier Aristu, Jose Luis Garcia-Sabrido, Miguel Angel Cuesta, Emilio del Valle, Fernando Lapuente, Bernardino Miñana, Miguel Ángel Morcillo, Jose Manuel Asencio, Javier Pascau

Open Access Research Article

C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway

Duo Xu, Meirong Li, Longyan Ran, Xiaochen Li, Xingwang Sun, Tao Yin

Research Article

A novel metabolism-related prognostic gene development and validation in gastric cancer

Xingxing Zhang, Xu Chen, Jiayun Liu, Yaqi Li, Jian Wu, Menglin Chen, Ruijuan Zhang, Xintian Xu, Tianyi Xu, Qingmin Sun

Research Article

The prognostic and predictive values of differential expression of exosomal receptor tyrosine kinases and associated with the PI3K/AKT/mTOR signaling in breast cancer patients undergoing neoadjuvant chemotherapy

Gamze Guney Eskiler, Nur Kazan, Ayten Haciefendi, Asuman Deveci Ozkan, Kayhan Ozdemir, Mirac Ozen, Havva Belma Kocer, Fahri Yilmaz, Suleyman Kaleli, Elvan Sahin, Cemil Bilir

Research Article

Classification of colorectal cancer into clinically relevant subtypes based on genes and mesenchymal cells

Cuicui Xiao, Xuegang Zhao, Xiaojie Li, Shuguang Zhu, Jing Cao, Hongping Chen, Danyang Li, Liuping Sha, Fei Huang, Ziqing Hei, Jiao Gong, Bo Hu

Research Article

Machine learning-based automated planning for hippocampal avoidance prophylactic cranial irradiation

Rodríguez de Dios N, Martínez Moñino A, Cristina Liu, Rafael Jiménez, Núria Antón, Miguel Prieto, Francesco Amorelli, Palmira Foro, Manuel Algara, Xavier Sanz, Ismael Membrive, Ana Reig, Jaume Quera, Enric Fernández-Velilla, Oscar Pera

Open Access Research Article

Adjuvant radiation therapy for older women with early-stage breast cancer: a propensity-matched SEER analysis

Nisha Wu, Qiao Tan, Xiaohan Su, Yewei Yuan, Lingmi Hou, Junyan Li

Research Article

Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types

Bingjie Guo, Yajing Wang, Wenyu Liu, Sailong Zhang

Brief Research Article

Clinical practice guidelines for the optimization of hemato-oncological care: the ICOPraxis

Consuelo Jordán de Luna, Esteve Fernández, Ricard Mesía, Ana Clopés

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.